BAWEI
837023
Yili Chuanning Biotechnology
301301
Shanghai Menon Animal Nutrition Technology
301156
4
Tongling Jieya Biologic Technology
301108
5
XI'AN WONDER
836419
CN Stock MarketDetailed Quotes
002657 Sinodata Co., Ltd.
- 19.85
- -0.97-4.66%
Trading May 15 13:06 CST
6.75BMarket Cap-101.28P/E (TTM)
20.55High19.83Low149.06KlotVolume20.55Open20.82Pre Close299.85MTurnover4.43%Turnover RatioLossP/E (Static)340.05MShares28.0952wk High3.75P/B6.68BFloat Cap10.0452wk Low22.90Limit Up336.36MShs Float185.90Historical High18.74Limit Down3.46%Amplitude6.67Historical Low--Dividend TTM20.12Avg Price94.84KlotAsk--Div YieldTTM100Lot Size47.49KlotBid
Sinodata Co., Ltd. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 41.38%174.59M | 16.46%1.17B | -19.70%533.29M | -33.68%301.81M | -53.40%123.49M | -18.74%1B | -9.76%664.15M | -10.03%455.06M | 73.49%265.02M | -23.23%1.23B |
| Operating revenue | 41.38%174.59M | 16.46%1.17B | -19.70%533.29M | -33.68%301.81M | -53.40%123.49M | -18.74%1B | -9.76%664.15M | -10.03%455.06M | 73.49%265.02M | -23.23%1.23B |
| Other operating revenue | ---- | -29.12%22.05M | ---- | 49.44%9.3M | ---- | 311.03%31.1M | ---- | 31.63%6.23M | ---- | -85.48%7.57M |
| Total operating cost | 36.32%218.47M | 14.17%1.24B | -13.62%634.64M | -25.04%372.46M | -44.85%160.27M | -13.82%1.09B | -6.90%734.69M | -8.99%496.87M | 55.12%290.59M | -24.71%1.26B |
| Operating cost | 51.02%144.32M | 18.57%942.04M | -21.34%422.35M | -36.52%233.49M | -58.00%95.56M | -18.11%794.51M | -7.21%536.92M | -7.95%367.85M | 105.06%227.55M | -25.76%970.27M |
| Operating tax surcharges | 7.75%497.33K | -62.16%1.04M | -68.62%799.34K | -69.70%712.7K | -78.26%461.56K | -21.99%2.75M | 75.04%2.55M | 82.96%2.35M | 126.34%2.12M | 18.82%3.52M |
| Operating expense | -0.95%8.28M | 4.97%40.72M | 0.70%26.17M | -3.74%16.99M | -2.43%8.36M | 1.77%38.8M | 0.51%25.99M | -4.02%17.65M | -11.83%8.57M | -23.07%38.12M |
| Administration expense | 9.12%21.03M | -13.19%93.76M | -10.11%66.14M | -5.41%43.41M | -7.20%19.27M | 16.36%108M | 11.18%73.58M | 0.92%45.9M | -15.60%20.77M | -26.42%92.82M |
| Financial expense | -71.70%-2.14M | -485.29%-8.98M | -686.34%-6.43M | -526.18%-3.76M | -444.39%-1.24M | -167.64%-1.53M | -15.44%-817.23K | 30.11%-601.22K | 70.51%-228.43K | -5,273.20%-573.04K |
| -Interest expense (Financial expense) | 16.21%477.93K | -14.81%803.78K | -3.06%690.92K | 33.21%590.43K | 69.36%411.25K | -16.85%943.55K | -13.39%712.69K | -25.44%443.24K | -31.09%242.83K | -38.47%1.13M |
| -Interest Income (Financial expense) | -53.21%-2.64M | -237.36%-10.05M | -187.21%-7.27M | -187.52%-4.46M | -271.44%-1.72M | -45.87%-2.98M | -46.23%-2.53M | 0.56%-1.55M | 61.16%-463.14K | 6.70%-2.04M |
| Research and development | 22.77%46.47M | 19.32%172.81M | 30.20%125.61M | 28.07%81.61M | 19.00%37.85M | -8.05%144.83M | -18.03%96.47M | -22.35%63.73M | -24.05%31.81M | -17.19%157.51M |
| Credit Impairment Loss | -134.46%-248.37K | -223.55%-5.52M | 136.41%3.42M | 12.88%1.94M | -52.26%720.72K | 73.68%-1.71M | 130.79%1.45M | 126.10%1.72M | 163.89%1.51M | -173.56%-6.48M |
| Asset Impairment Loss | -119.95%-99.31K | 100.23%133.72K | 39.37%-206.35K | 222.14%294.78K | 537.37%497.89K | 65.42%-58.37M | -156.05%-340.33K | -133.91%-241.35K | -131.26%-113.84K | -610.81%-168.81M |
| Other net revenue | -45.50%5.3M | 340.97%23.94M | -42.06%27.41M | -33.47%21.56M | -22.60%9.73M | 92.52%-9.93M | 0.15%47.32M | 16.42%32.41M | -20.03%12.57M | -1,181.09%-132.77M |
| Fair value change income | 97.39%-17.2K | 89.09%-916.2K | 52.88%-222.93K | -382.75%-605.26K | -67.64%-659.23K | -246.84%-8.4M | -145.45%-473.11K | 121.49%214.06K | 78.72%-393.24K | -195.44%-2.42M |
| Invest income | -40.87%4.73M | -50.58%25.34M | -50.88%21.35M | -39.09%17.73M | -26.83%8M | 45.44%51.27M | 0.10%43.46M | -12.68%29.1M | -40.34%10.93M | -19.56%35.25M |
| -Including: Investment income associates | -17.69%1.04M | -72.44%4.98M | -55.51%5.93M | -26.46%6.45M | -68.99%1.27M | 526.95%18.06M | -16.73%13.33M | -23.29%8.78M | -47.47%4.09M | -431.52%-4.23M |
| Asset deal income | ---33.37K | 241.03%152.61K | 180.51%175.43K | 211.41%194.75K | ---- | -118.96%-108.21K | 35.52%62.54K | 4,763.65%62.54K | ---- | 99.86%-49.42K |
| Other revenue | -17.07%971.49K | -35.74%4.75M | -8.26%2.9M | 29.39%2.02M | 83.94%1.17M | -24.17%7.39M | -60.76%3.16M | 14.15%1.56M | -48.81%636.85K | 97.44%9.74M |
| Operating profit | -42.64%-38.58M | 46.88%-50.69M | -218.44%-73.94M | -421.80%-49.08M | -108.04%-27.05M | 40.91%-95.41M | -293.04%-23.22M | 23.84%-9.41M | 31.06%-13M | -101.61%-161.46M |
| Add:Non operating Income | ---- | -98.44%17.7K | -82.92%4.46K | --4.46K | ---- | 48.72%1.13M | -96.56%26.09K | ---- | ---- | 170.78%762.35K |
| Less:Non operating expense | -55.43%100K | 24.42%4.4M | 37.66%4.38M | 1,598.59%231.03K | 1,549.56%224.36K | 21.60%3.54M | 10.79%3.18M | -99.53%13.6K | 244.33%13.6K | -53.82%2.91M |
| Total profit | -41.83%-38.68M | 43.70%-55.07M | -196.94%-78.32M | -423.45%-49.31M | -109.55%-27.27M | 40.21%-97.81M | -228.84%-26.37M | 38.11%-9.42M | 31.00%-13.01M | -90.02%-163.6M |
| Less:Income tax cost | -97.68%4.47K | -96.79%337.27K | -99.83%21.5K | -94.37%221.53K | -80.48%192.64K | 112.88%10.52M | 229.94%12.8M | 56.86%3.94M | 176.01%986.91K | -25.08%4.94M |
| Net profit | -40.85%-38.68M | 48.86%-55.41M | -99.97%-78.34M | -270.82%-49.53M | -96.15%-27.47M | 35.73%-108.33M | -229.20%-39.18M | 24.66%-13.36M | 27.15%-14M | -81.83%-168.54M |
| Net profit from continuing operation | -40.85%-38.68M | 48.86%-55.41M | -99.97%-78.34M | -270.82%-49.53M | -96.15%-27.47M | 35.73%-108.33M | -229.20%-39.18M | 24.66%-13.36M | 27.15%-14M | -81.83%-168.54M |
| Less:Minority Profit | -76.42%5.25 | 100.19%54.25 | -41.78%48.07 | -30.16%38.92 | -19.38%22.26 | -16,361.92%-28.29K | -43.18%82.56 | -13.13%55.73 | -12.98%27.61 | 1,422.05%173.97 |
| Net profit of parent company owners | -40.85%-38.68M | 48.84%-55.41M | -99.97%-78.34M | -270.82%-49.53M | -96.15%-27.47M | 35.74%-108.3M | -229.19%-39.18M | 24.66%-13.36M | 27.15%-14M | -81.83%-168.54M |
| Earning per share | ||||||||||
| Basic earning per share | -40.84%-0.1138 | 48.94%-0.1634 | -92.42%-0.2309 | -275.00%-0.15 | -102.00%-0.0808 | 36.00%-0.32 | -200.00%-0.12 | 20.00%-0.04 | 33.33%-0.04 | -85.19%-0.5 |
| Diluted earning per share | -40.84%-0.1138 | 48.94%-0.1634 | -92.42%-0.2309 | -275.00%-0.15 | -102.00%-0.0808 | 36.00%-0.32 | -200.00%-0.12 | 20.00%-0.04 | 33.33%-0.04 | -85.19%-0.5 |
| Other composite income | ||||||||||
| Total composite income | -40.85%-38.68M | 48.86%-55.41M | -99.97%-78.34M | -270.82%-49.53M | -96.15%-27.47M | 35.73%-108.33M | -229.20%-39.18M | 24.66%-13.36M | 27.15%-14M | -81.83%-168.54M |
| Total composite income of parent company owners | -40.85%-38.68M | 48.84%-55.41M | -99.97%-78.34M | -270.82%-49.53M | -96.15%-27.47M | 35.74%-108.3M | -229.19%-39.18M | 24.66%-13.36M | 27.15%-14M | -81.83%-168.54M |
| Total composite income of minority owners | -76.42%5.25 | 100.19%54.25 | -41.78%48.07 | -30.16%38.92 | -19.38%22.26 | -16,361.92%-28.29K | -43.18%82.56 | -13.13%55.73 | -12.98%27.61 | 1,422.05%173.97 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.